US FDA adcom supports Leqembi for full approval

BioWorld, June 9, 2023: BioWorld news explains that FDA Advisory Committee supports Leqembi for Mild Cognitive Impairment (MCI) caused by Alzheimer’s and quotes our statement that MCI can go away without drugs, which means that Leqembi’s risks of brain swelling and bleeding will often greatly outweigh the potential benefits.

Read More »

Palliative Care for Serious Diseases

Palliative care is often misunderstood as meaning a patient will not get “real treatment.” That is not accurate. Instead, palliative care offers a different type of treatment. Rather than focusing on curing a disease and exposing patients to aggressive treatment and therapy, palliative care focuses on improving the quality of life and relieving patients’ pain. Many patients receive both palliative and curative care at the same time, and benefit from the combination of treatment types. 

Read More »